Novel coronavirus pneumonia, a novel coronavirus pneumonia experimental drug, will become the standard drug for new crown pneumonia, according to the US top infectious disease official. Early results of a pivotal clinical trial on Wednesday showed that the drug could help speed up the recovery of new crown pneumonia in, Remdesivir.
Preliminary results from the U.S. government showed that patients treated with ridcivir recovered 31% faster than those treated with placebo, a result Dr. Anthony Fauci praised as "extremely important.".
"I hope they do as soon as possible." US President trump was asked if he would like the FDA to grant radcivir emergency use rights. "We want everything to be safe, but we also want to see very quick approvals, especially for those that work."
The high-profile drug has had an impact on market trends in the past few weeks, and several previous studies have shown mixed results, and fudge cautioned that the latest data still needs to be analyzed.
Geely's shares rose more than 5% on Wednesday to $83.14, up 27% this year.
Ridcivir is expected because there is no approved treatment or preventive vaccine for the new coronavirus, and doctors are desperately looking for any way to change the course of the disease. The virus attacks the lungs and can cause organ failure in severe patients.
Hot Model No.: